Nebraska Statutes
§ 71-9607 — Death of patient; effect on debt
Nebraska·Ch. 71 Public Health and Welfare
If an eligible patient dies while being treated by an investigational drug, biological product, or device, the manufacturer may not seek reimbursement for any outstanding debt related to the treatment or lack of insurance due to the treatment from the eligible patient's or his or her caretaker's estate.
Free access — add to your briefcase to read the full text and ask questions with AI
Nebraska § 71-9607 (Death of patient; effect on debt) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
Source: Laws 2018, LB117, § 7.
Nearby Sections
15
§ 71-1002
Repealed. Laws 2019, LB559, § 6§ 71-1005
Repealed. Laws 2019, LB559, § 6§ 71-1006
Repealed. Laws 2019, LB559, § 6§ 71-1007
Board; purpose§ 71-101
Transferred to section38-101§ 71-101.01
Repealed. Laws 2007, LB 463, § 1319§ 71-101.02
Repealed. Laws 1988, LB 1100, § 185§ 71-102
Transferred to section38-121§ 71-103
Transferred to section38-129§ 71-104.01
Transferred to section38-131§ 71-105
Transferred to section38-122